| abstract |
The present disclosure relates to aniline derivatives of the general formula I with the substituents defined in the specification. Also disclosed is their use as serotonin reuptake inhibitors and preferably also norepinephrine reuptake inhibitors in the treatment of depression, anxiety, affective disorders, and pain disorders, attention deficit hyperactivity disorder (ADHD) and stress urinary incontinence. |